Kailera Therapeutics, Inc. (KLRA): SCHEDULE 13G filed Aug 14, 2026

Form type

SCHEDULE 13G

Filing date

Aug 14, 2026

Accession number

0001193125-26-352133

Filer

Kailera Therapeutics, Inc. (CIK 2096997)